This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Marian Paul Segeth: Innovator in Pharmaceutical Compounds
Introduction
Marian Paul Segeth is a notable inventor based in Idstein, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development of compounds derived from fermentation processes.
Latest Patents
Segeth holds a patent for "Coniosulfides and their derivatives, processes for preparing them, and their use as pharmaceuticals." This invention relates to compounds formed during fermentation by the microorganism Udagawa, DSM 13856, or its mutations and variants. The patent also details a process for preparing these compounds and their application in treating degenerative neuropathics and Alzheimer's disease.
Career Highlights
Marian Paul Segeth is associated with Aventis Pharma Deutschland, GmbH, where he has been instrumental in advancing pharmaceutical research. His work has led to the development of innovative solutions aimed at improving patient care and treatment options.
Collaborations
Throughout his career, Segeth has collaborated with esteemed colleagues such as Laszlo Vertesy and Klaus Ehrlich. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Marian Paul Segeth's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the field positively, paving the way for future developments in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile